NervGen Pharma Financials
| NGENF Stock | USD 1.87 0.05 2.60% |
With this module, you can analyze NervGen financials for your investing period. You should be able to track the changes in NervGen Pharma individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
NervGen |
Understanding current and past NervGen Pharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of NervGen Pharma's financial statements are interrelated, with each one affecting the others. For example, an increase in NervGen Pharma's assets may result in an increase in income on the income statement.
The data published in NervGen Pharma's official financial statements typically reflect NervGen Pharma's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving NervGen Pharma's quantitative information. For example, before you start analyzing numbers published by NervGen accountants, it's essential to understand NervGen Pharma's liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
NervGen Pharma Stock Summary
NervGen Pharma competes with Evolution Mining, Vindicator Silver, Nike, Boot Barn, and Lululemon Athletica. NervGen Pharma Corp., together with its subsidiaries, engages in the discovery, development, and commercialization of pharmaceutical treatments for medical conditions related to nervous system damage. NervGen Pharma Corp. was incorporated in 2017 and is based in Vancouver, Canada. NERVGEN PHARMA operates under Biotechnology classification in the United States and is traded on OTC Exchange.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| Business Address | 2955 Virtual Way, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.nervgen.com |
| Phone | 778 731 1711 |
| Currency | USD - US Dollar |
NervGen Pharma Key Financial Ratios
There are many critical financial ratios that NervGen Pharma's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that NervGen Pharma Corp reports annually and quarterly.| Return On Equity | -1.42 | |||
| Return On Asset | -0.67 | |||
| Beta | 1.7 |
NervGen Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining NervGen Pharma's current stock value. Our valuation model uses many indicators to compare NervGen Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NervGen Pharma competition to find correlations between indicators driving NervGen Pharma's intrinsic value. More Info.NervGen Pharma Corp is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NervGen Pharma's earnings, one of the primary drivers of an investment's value.NervGen Pharma Corp Systematic Risk
NervGen Pharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. NervGen Pharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on NervGen Pharma Corp correlated with the market. If Beta is less than 0 NervGen Pharma generally moves in the opposite direction as compared to the market. If NervGen Pharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one NervGen Pharma Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of NervGen Pharma is generally in the same direction as the market. If Beta > 1 NervGen Pharma moves generally in the same direction as, but more than the movement of the benchmark.
NervGen Pharma November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of NervGen Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of NervGen Pharma Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of NervGen Pharma Corp based on widely used predictive technical indicators. In general, we focus on analyzing NervGen OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build NervGen Pharma's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.93 | |||
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 33.14 | |||
| Value At Risk | (6.09) | |||
| Potential Upside | 6.79 |
Complementary Tools for NervGen OTC Stock analysis
When running NervGen Pharma's price analysis, check to measure NervGen Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NervGen Pharma is operating at the current time. Most of NervGen Pharma's value examination focuses on studying past and present price action to predict the probability of NervGen Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NervGen Pharma's price. Additionally, you may evaluate how the addition of NervGen Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |